Table 3.
Summary of IFX related adverse events
| Adverse event | IBD (CD + UC) | Crohn’s disease | Ulcerative colitis |
| Acute infusion reaction (%) (Mild, moderate, severe) | 3/50 (6) | 3/40 (7.5) | 0 |
| Delayed infusion reaction (%) (Serum sickness-like) | 1/50 (2) | 1/40 (2.5) | 0 |
| Opportunistic infection (%) | 9/50 (18) | 8/40 (20) 5 HSV 1 VZV 2 atypical pneumoniae | 1/10 (10) 1 HSV |
| Lymphoproliferative diseases | 0 | 0 | 0 |
| Malignant disorder (%) | 3/50 (6) | 2/40 (5) | 1/10 (10) |
HSV: Herpes simplex virus; VZV: Varicella-zoster virus.